España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Champion Industries
CHMP
OTCEM
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.00010
At close: Oct 13, 10:02 AM EDT
Get Report
Comment
Champion Industries (CHMP) Forecast
News
Earnings
Champion Industries (CHMP) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Champion Industries (OTC:CHMP) Stock
Champion Industries Stock (OTC: CHMP)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, March 01, 2019
CHMP Recommends Lexicon And Sanofi's Zynquist...
Benzinga Newsdesk
Friday, September 14, 2012
Champion Industries /WV Reports Q3 EPS $-0.10
Benzinga
Friday, February 17, 2012
Abbott Receives Positive Opinion for HUMIRA in Ulcerative Colitis from EMA's CHMP
Benzinga
CHMP Recommends Approval of BYETTA for Use With Basal Insulin
Benzinga
Monday, February 13, 2012
Alexza Pharmaceuticals Receives Day 80 Assessment Report for ADASUVE MAA
Benzinga
Monday, January 30, 2012
Allos Therapeutics Requests Re-Examination of CHMP Opinion on FOLOTYN in PTCL at the European Medicines Agency
Benzinga
Friday, September 09, 2011
Champion Reports Q3 EPS $0.09 vs ($0.07) Prio...
Benzinga
Monday, May 23, 2011
UPDATE: Piper Jaffray Upgrading Acorda Therapeutics
Benzinga
Friday, January 28, 2011
Cloud Computing Deal with Verizon and Terremark Creates Top Trader for Investors
Benzinga
Vaccines Pull Down NVS Q4 Earnings - Analyst Blog
Benzinga
Vaccines Pull Down NVS Q4 Earnings - Analyst Blog
Benzinga
Novartis to Buy Genoptix - Analyst Blog
Benzinga
Novartis to Buy Genoptix - Analyst Blog
Benzinga
Wednesday, January 26, 2011
CHMP Stands Negative on MKGAF Drug - Analyst Blog
Benzinga
CHMP Stands Negative on MKGAF Drug - Analyst Blog
Benzinga
Tuesday, January 25, 2011
Boost for VRX-GSK Epilepsy Drug - Analyst Blog
Benzinga
Boost for VRX-GSK Epilepsy Drug - Analyst Blog
Benzinga
Monday, January 24, 2011
Biogen-Acorda MS Drug Faces Setback - Analyst Blog
Benzinga
Biogen-Acorda MS Drug Faces Setback - Analyst Blog
Benzinga
Thursday, January 13, 2011
Lucentis Gains EU Approval for DME - Analyst Blog
Benzinga
Lucentis Gains EU Approval for DME - Analyst Blog
Benzinga
Monday, December 20, 2010
ITMN's Esbriet Backed for EU Nod - Analyst Blog
Benzinga
ITMN's Esbriet Backed for EU Nod - Analyst Blog
Benzinga
Friday, December 17, 2010
InterMune Continues To Skyrocket (ITMN)
Benzinga
Top Narrow Based Indexes For December 17 (ITMN, SMI, HSFT)
Benzinga
Morning Market Movers (ITMN, BASI, NYMX, MI)
Benzinga
Benzinga's Top Pre-Market NASDAQ Gainers (ITMN, YRCW, TTWO, ORCL)
Benzinga
Monday, November 29, 2010
Merck KGaA MS Drug Faces Glitch - Analyst Blog
Benzinga
Merck KGaA MS Drug Faces Glitch - Analyst Blog
Benzinga
Tuesday, September 28, 2010
Positive EU Opinion for AZN Drug - Analyst Blog
Benzinga
Friday, September 10, 2010
Champion Reports Results for 3rd Quarter
Benzinga
Wednesday, September 08, 2010
Earnings Scheduled For September 8 (SFD, CIEN, MW, DFZ, TLB, UNFI, AVAV, TITN, RURL, CHMP, HITK, JTX, NAV, NTWK, REX, STRM)
Benzinga
Tuesday, September 07, 2010
Gilead Files MAA for HIV Drug - Analyst Blog
Benzinga
Friday, August 27, 2010
European Approval for Shire Drug - Analyst Blog
Benzinga
Friday, August 20, 2010
Before The Bell – A Glimpse Of The Market Today
Benzinga
US Stock Futures Face Dismal Day Again
Benzinga
Earnings Scheduled For August 20 (SJM, ANN, HRL, COCO, KIRK, CHMP, MTRX, HIBB)
Benzinga
Friday, July 16, 2010
Glaxo's Avandia Backed by FDA - Analyst Blog
Benzinga
Monday, July 12, 2010
Testing Times for Glaxo's Avandia - Analyst Blog
Benzinga
Monday, June 28, 2010
Good News for Shire - Analyst Blog
Benzinga
Benzinga’s Top Pre-Market Losers (FFCH, MTXX, AMZN, SHPGY)
Benzinga
Tuesday, June 01, 2010
Zacks Analyst Blog Highlights: Ford Motor, General Motor, Tata Motors, Amgen and GlaxoSmithKline - Press Releases
Benzinga
Friday, May 28, 2010
EU Approval for Amgen's Prolia - Analyst Blog
Benzinga
Wednesday, April 28, 2010
Zacks Analyst Blog Highlights: United States Steel Corporation, Merck, Forest Laboratories, GlaxoSmithKline and Pfizer - Press Releases
Benzinga
Tuesday, April 27, 2010
Merck Acquires Daxas Rights - Analyst Blog
Benzinga
Thursday, April 22, 2010
Conditional Approval for Glaxo Drug - Analyst Blog
Benzinga
Monday, April 19, 2010
Additional Indication for OSI Drug - Analyst Blog
Benzinga
Wednesday, March 31, 2010
NVS Wins Approval for Vaccine - Analyst Blog
Benzinga
Monday, March 22, 2010
Good News for OSI Pharma - Analyst Blog
Benzinga
Friday, March 19, 2010
Benzinga’s News Roundup (NXY, PALM, TTEK, PERY, OSIP)
Benzinga
Show More
